Iliac Stent Market Report 2026

Iliac Stent Market Overview

• Iliac Stent market size has reached to $1.09 billion in 2025 • Expected to grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Rising Prevalence of Peripheral Artery Diseases Fuels The Iliac Stent Market • Market Trend: Advancements In Iliac Stent Technologies With FDA Approval Enhances Safety, Innovation, and Accessibility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Iliac Stent Market?

Iliac stents are specialized medical devices designed to treat atherosclerosis in the iliac arteries, which are located in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to expand and support narrowed or blocked arteries. The main types of iliac stents are self-expandable stents, balloon-expandable stents, and others. Self-expandable stents are medical devices used to treat narrowed or blocked blood vessels in various parts of the body, such as the coronary arteries, peripheral arteries, and other tubular structures. The various artery lesions include common iliac artery lesions, severe calcified lesions, and complete obstructive lesions used by various end-users such as hospitals, outpatient facilities, and others.

What Is The Iliac Stent Market Growth Forecast?

The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing demand for minimally invasive treatments, increasing incidence of lifestyle-related vascular disorders, expanding access to interventional cardiology services, rising healthcare expenditure in emerging economies, increasing focus on early vascular intervention. Major trends in the forecast period include rising adoption of minimally invasive peripheral interventions, increasing preference for self-expandable iliac stents, growing use of drug-eluting and covered stents in complex lesions, shift toward outpatient and day-care endovascular procedures, expansion of iliac stent usage in severe and calcified lesions.

Global Iliac Stent Market Segmentation

1) By Type: Self-Expandable Stents, Balloon-Expandable Stents, Other Types 2) By Artery Lesions: Common Iliac Artery Lesions, Severe Calcified Lesions 3) By End-Users: Hospitals, Outpatient Facilities, Other End-Users Subsegments: 1) By Self-Expandable Stents: Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents 2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents, Drug-Eluting Balloon-Expandable Stents 3) By Other Types: Covered Stents, Hybrid Stents

What Is The Driver Of The Iliac Stent Market?

The increasing prevalence of peripheral artery diseases is expected to propel the growth of the iliac stent market going forward. Peripheral artery disease (PAD) is a circulatory condition characterized by the narrowing or blockage of arteries outside the heart and brain. The increasing prevalence of peripheral artery diseases is due to smoking, the aging population, hypertension, and diabetes. Iliac stenting is an effective treatment option for patients with PAD, offering improved blood flow, symptom relief, and prevention of complications while also being minimally invasive and associated with a high success rate. For instance, in July 2023, according to the Society For Cardiovascular Angiography And Interventions, a US-based organization, PAD affects 8-10 million Americans each year, and it is estimated that 19 million Americans will have PAD by 2050. Therefore, the increasing prevalence of peripheral artery diseases drives the iliac stent industry.

Key Players In The Global Iliac Stent Market

Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH

Global Iliac Stent Market Trends and Insights

Major companies operating in the iliac stent market are developing innovative products such as iCast to improve patient outcomes and reduce the risk of complications. iCast-covered stent system represents an innovative approach to treating iliac artery occlusive disease, offering improved performance and reduced risk of complications compared to traditional bare-metal stents. For instance, in October 2023, Getinge, a Sweden-based healthcare company, announced the commercial availability of the iCast-covered stent system in the USA for treating iliac arterial occlusive disease approved by the Food and Drug Administration (FDA). This indication reflects Getinge's commitment to bringing high-quality products and support to US clinicians and hospital systems to treat this severe condition.

What Are Latest Mergers And Acquisitions In The Iliac Stent Market?

In February 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Cardiovascular Systems Inc. (CSI) for an undisclosed amount. With this acquisition, Abbott Laboratories aims to enhance its vascular device offerings by integrating CSI's innovative atherectomy system into its portfolio. Cardiovascular Systems Inc. is a US-based medical technology company that manufactures iliac stents.

Regional Outlook

North America was the largest region in the iliac stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Iliac Stent Market?

The iliac stents market consists of sales of coronary stents, biliary stents, and ureteral stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.